Aquestive Therapeutics Inc (AQST) - News Archive

Aquestive Therapeutics Expands Intellectual Property for Anaphylm Amidst Challenging Financial Landscape Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company known for pioneering advanced medication del...

In the fast-paced world of pharmaceuticals, where innovation often dances on the precipice of financial stability, Aquestive Therapeutics Inc. (NASDAQ: AQST) stands at a crossroads. As the company prepares to unveil new...

As 2025 unfolds, a spotlight shines on Aquestive Therapeutics Inc. (NASDAQ: AQST), a Warren, N.J.-based pharmaceutical company currently navigating both turbulent fiscal waters and vital advancements in pediatric neurol...

Factual In a significant advancement for pediatric neurology, Aquestive Therapeutics has announced that the United States Food and Drug Administration (U.S. FDA) has granted Orphan Drug Exclusivity for its product, Libe...

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm (epinephrine) Sublingual FilmWARREN, N.J., April...

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pioneering pharmaceutical company dedicated to delivering impactful advancements in patient care through innovative science and advanced delivery technologies, has announce...

Aquestive Therapeutics Completes Underwritten Public Offering and Raises $75 MillionAquestive Therapeutics, a pharmaceutical company dedicated to bringing innovative medicines to patients and improving their lives throu...

Aquestive Therapeutics Announces Proposed Public Offering of Common StockIn a recent press release, Aquestive Therapeutics, a pharmaceutical company focused on innovative science and delivery technologies, has revealed...

Aquestive Therapeutics, a leading pharmaceutical company focused on developing innovative science and delivery technologies, recently announced positive topline clinical data from its Phase 3 pivotal pharmacokinetic (PK...

Aquestive Therapeutics Presents Positive Pharmacokinetic and Pharmacodynamic Data for Anaphylm at AAAAI Annual MeetingWarren, N.J., (Date) - Aquestive Therapeutics, a leading pharmaceutical company dedicated to advancin...

Aquestive Therapeutics, a leading pharmaceutical company focused on using innovative science and delivery technologies to revolutionize patient care, has recently made a significant breakthrough in the field of epinephr...